Digital Breast Tomosynthesis:
An Intensive Case Review

Recording of a live webinar presented on April 3, 2012
 

A certified, one-hour prerecorded webinar for radiologists and other healthcare professionals who treat and manage patients with breast disease.

Format: Archived Webinar
MD Credit:  1.0 AMA PRA Category 1 (Available for physician credit only)
RT Credit:   No ARRT credit available
Fee for Credit Certificate: $0



Click to watch a preview from this presentation
To enroll in this activity, click the ENROLL NOW icon to the left.

Course Overview

In February 2011, the FDA approved digital breast tomosynthesis (DBT) for use in breast imaging. The approval of DBT adds to the already wide range of breast screening and diagnostic imaging options available to physicians.

With FDA approval of DBT, the medical community is faced with evaluating DBT in terms of providing improved care for their patient population and the impact of this new technology on their medical practice. This evaluation process involves consideration of the pros and cons of the technology compared to their current practice, patient selection criteria, and operational concerns.

Faculty will begin the session with an overview of DBT technology and then provide an intensive review of malignant, benign, and dense breast cases.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

• Evaluate the potential role of DBT for enhancing the screening and diagnosis of breast disease
• Assess the role of DBT for the diagnosis of malignant and benign lesions
• Define the role of DBT for different breast densities

Accreditation & Credit

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and the International Center for Postgraduate Medical Education (ICPME). PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Participate

There are no fees to participate in this activity. Each participant will need a computer with internet access.

• To register, click ENROLL NOW, then CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.
• Click the blue link. Complete the precourse evaluation and click SUBMIT.
• Once the precourse evaluation is submitted, click on the blue link again to view the course.
• Click on PLAYBACK. To view the streaming video, you may have to download the WebEx Player or Java.

Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.

How to Receive Credit
There are no fees to participate in this activity.

• View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
• At the conclusion of the lecture, close the WebEx Player window. You will be redirected to the ICPME website.
• From the COURSE HOME page, click the buttons for POSTTEST and for EVALUATION.
• A passing grade of at least 75% is required to receive credit.  You may take the test up to three times.
• Upon receipt of a passing grade, click the certificate tab to print a credit certificate.

Faculty

Stephen L. Rose, MD
Stephen L. Rose is Founder and President of Houston Breast Imaging, Houston’s largest group of breast imaging specialists.

Dr. Rose is a graduate of the Johns Hopkins University School of Medicine. His residency in Diagnostic Radiology was completed at the University of Texas at Houston, including training at M.D. Anderson, Texas Children’s, Memorial Hermann, and St. Joseph’s Hospital of Houston, Texas. He is a board certified, nationally known breast radiologist and has dedicated his practice to the diagnosis of early breast cancer for more than two decades.

Dr. Rose was part of a multicenter national trial investigating digital breast tomosynthesis.

Conflict of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty below have reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Stephen L. Rose, MD has received consulting fees from Hologic, Inc.

The planners and managers below reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD
Samantha Mattiucci, PharmD
Linda McLean, MS
Victoria Phoenix, BS
Lisa Schleelein, MEd
Jan Schultz, RN, MSN, CCMEP
Patricia Staples, MSN, NP-C, CCRN


Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME, and Hologic. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10



JOINTLY SPONSORED BY

               
 


THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM



Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.